BE649574A - - Google Patents

Info

Publication number
BE649574A
BE649574A BE649574DA BE649574A BE 649574 A BE649574 A BE 649574A BE 649574D A BE649574D A BE 649574DA BE 649574 A BE649574 A BE 649574A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE649574A publication Critical patent/BE649574A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE649574D 1963-06-28 1964-06-22 BE649574A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US291288A US3159547A (en) 1963-06-28 1963-06-28 Method of lowering blood pressure with 4-(2-amino-4-pyrimidylamino)-benzene-sulfonamide

Publications (1)

Publication Number Publication Date
BE649574A true BE649574A (fr) 1964-12-22

Family

ID=23119700

Family Applications (1)

Application Number Title Priority Date Filing Date
BE649574D BE649574A (fr) 1963-06-28 1964-06-22

Country Status (4)

Country Link
US (1) US3159547A (fr)
BE (1) BE649574A (fr)
FR (1) FR3539M (fr)
GB (1) GB1032266A (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3432493A (en) * 1966-06-27 1969-03-11 Abbott Lab Substituted sulfanilamides
US3775168A (en) * 1972-02-28 1973-11-27 Cities Service Co Process for protecting a substrate with an n{11 -pyrimidylamino-arylsulfonamide intumercent agent
TWI329105B (en) 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
IL166241A0 (en) 2002-07-29 2006-01-15 Rigel Pharmaceuticals Inc Method of treating or preventing autoimmune diseases with 2,4-pyrimidinedinediamine compounds
ES2421139T3 (es) * 2003-07-30 2013-08-29 Rigel Pharmaceuticals, Inc. Compuestos de 2,4-pirimidindiamina para su uso en el tratamiento o la prevención de enfermedades autoinmunitarias
ATE540035T1 (de) 2004-11-24 2012-01-15 Rigel Pharmaceuticals Inc Spiro-2,4-pyrimidindiamin-verbindungen und ihre verwendungen
JP2008540436A (ja) * 2005-05-03 2008-11-20 ライジェル ファーマシューティカルズ, インコーポレイテッド Jakキナーゼインヒビターおよびそれらの使用

Also Published As

Publication number Publication date
GB1032266A (en) 1966-06-08
FR3539M (fr) 1965-09-13
US3159547A (en) 1964-12-01

Similar Documents

Publication Publication Date Title
AR142945A1 (fr)
AT260747B (fr)
BE627012A (fr)
BE620325A (fr)
BE626986A (fr)
BE627023A (fr)
BE465565A (fr)
BE507458A (fr)
BE627145A (fr)
BE621232A (fr)
BE644121A (fr)
BE626803A (fr)
BE645781A (fr)
BE626915A (fr)
BE623117A (fr)
BE626590A (fr)
BE644766A (fr)
BE626938A (fr)
BE627141A (fr)
BE626358A (fr)
BE625880A (fr)
BE547422A (fr)
BE612803A (fr)
BE644277A (fr)
BE608372A (fr)